Detalhe da pesquisa
1.
Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors.
Cancer Treat Res
; 180: 251-279, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32215873
2.
Genetic basis for clinical response to CTLA-4 blockade in melanoma.
N Engl J Med
; 371(23): 2189-2199, 2014 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25409260
3.
Immunologic correlates of the abscopal effect in a patient with melanoma.
N Engl J Med
; 366(10): 925-31, 2012 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22397654
4.
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.
Blood
; 120(24): 4882-91, 2012 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23012326
5.
Depression, cytokines, and pancreatic cancer.
Psychooncology
; 23(3): 339-45, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24136882
6.
B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.
J Immunol
; 189(8): 4165-74, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22972920
7.
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.
Proc Natl Acad Sci U S A
; 108(40): 16723-8, 2011 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21933959
8.
A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI).
Cytometry A
; 83(8): 728-38, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23788464
9.
Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanoma.
Ann Surg Oncol
; 20(9): 3106-11, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23681603
10.
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results.
Nat Med
; 29(7): 1718-1727, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429923
11.
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.
Blood
; 116(2): 171-9, 2010 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20400682
12.
Modulation of CTLA-4 and GITR for cancer immunotherapy.
Curr Top Microbiol Immunol
; 344: 211-44, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20563707
13.
Hallmarks of Resistance to Immune-Checkpoint Inhibitors.
Cancer Immunol Res
; 10(4): 372-383, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362046
14.
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.
Cancer Immunol Immunother
; 60(8): 1137-46, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21465316
15.
A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols.
J Transl Med
; 9: 108, 2011 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21745365
16.
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
Blood
; 114(3): 555-63, 2009 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19465693
17.
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.
Proc Natl Acad Sci U S A
; 105(51): 20410-5, 2008 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074257
18.
Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition.
Eur J Cancer
; 157: 493-510, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561127
19.
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.
Int J Cancer
; 126(4): 909-18, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19728336
20.
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.
Cancer Immunol Immunother
; 59(10): 1467-79, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20532500